Literature DB >> 225530

Simian virus 40-host cell interaction during lytic infection.

E L Gershey.   

Abstract

Both exponentially growing and serum-arrested subcloned CV-1 cell cultures were infected with simian virus 40 (SV40). By 24 h after infection 96% of the nuclei of these permissive cells contained SV40 T-antigen. Analysis of the average DNA content per cell at various times after infection indicated that by 24 h most of the cells contained amounts of DNA similar to those normally found in G(2) cells. Analysis of cell cycle distributions indicated that a G(2) DNA complement was maintained by over 90% of the cells in the infected populations 24 to 48 h postinfection. Cells continued to synthesize SV40 DNA during the first 50 h after infection, and cytopathic effect was first observed 60 h after inoculation. After infection the number of mitotic cells that could be recovered by selective detachment decreased precipitously and was drastically reduced by 24 h. A study of the kinetics of decline in the number of mitotic cells suggests that this decline is related to an event during the cell cycle at or near the G(1)-S-phase border upon which commencement of SV40 DNA replication apparently depends. It was concluded that after SV40 infection, stationary cells are induced to cycle, and cycling cells complete one round of cellular DNA synthesis but do not divide. Although the infected cells continue to synthesize viral DNA, they do not appear able to reinitiate cellular DNA replication units. These results imply that the abundance of T-antigen (produced independently of cell cycle phase) in the presence of the enzymes required for continued DNA synthesis is not sufficient for reinitiation of cellular DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225530      PMCID: PMC353300     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Stimulation of non-histone chromosomal protein synthesis in simian virus 40-infected simian cells.

Authors:  H Iida; K Oda
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

2.  Folding of the DNA double helix in chromatin-like structures from simian virus 40.

Authors:  J E Germond; B Hirt; P Oudet; M Gross-Bellark; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

3.  Synthesis of Superhelical Simian Virus 40 Deoxyribonucleic Acid in Cell Lysates*.

Authors:  M L DePamphilis; P Beard; P Berg
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

4.  A simplifying concept in tumor virology: virus-specific "pleiotropic effectors".

Authors:  R Weil; E Salomon; E May; P May
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

5.  The semiautonomous replicon: a molecular model for the oncogenicity of SV40.

Authors:  R G Martin; J Y Chou; J Avila; R Saral
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

6.  Proteins in intracellular simian virus 40 nucleoportein complexes: comparison with simian virus 40 core proteins.

Authors:  W Meinke; M R Hall; D A Goldstein
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

7.  Structural proteins of simian virus 40. I. Histone characteristics of low-molecular-weight polypeptides.

Authors:  D M Pett; M K Estes; J S Pagano
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

8.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

9.  Analysis of the replication pattern of Chinese hamster chromosomes using 5-bromodeoxyuridine suppression of 33258 Hoechst fluorescence.

Authors:  E Stubblefield
Journal:  Chromosoma       Date:  1975-12-10       Impact factor: 4.316

10.  Fluorescence analysis of late DNA replication in human metaphase chromosomes.

Authors:  S A Latt
Journal:  Somatic Cell Genet       Date:  1975-07
View more
  12 in total

1.  Inhibition of vimentin synthesis and disruption of intermediate filaments in simian virus 40-infected monkey kidney cells.

Authors:  A Ben-Ze'ev
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

2.  Reversible growth arrest in simian virus 40-transformed human fibroblasts.

Authors:  R M Hoffman; S J Jacobsen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

Review 3.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

4.  Effect of simian virus 40 on the temporal and spatial organization of DNA replication in Muntjac cells.

Authors:  B R Jasny; J M Wright; L A Smith; E L Gershey; I Tamm
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

5.  Reversible repression and activation of measles virus infection in neural cells.

Authors:  C A Miller; D R Carrigan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest.

Authors:  F M Jault; J M Jault; F Ruchti; E A Fortunato; C Clark; J Corbeil; D D Richman; D H Spector
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  PCNA damage caused by antineoplastic drugs.

Authors:  Soo In Bae; Ran Zhao; Robert M Snapka
Journal:  Biochem Pharmacol       Date:  2008-09-06       Impact factor: 5.858

8.  Simian virus 40 minichromosomes as targets for retroviral integration in vivo.

Authors:  P M Pryciak; H P Müller; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  Simian virus 40 large T-antigen function is required for induction of tetraploid DNA content during lytic infection.

Authors:  T D Friedrich; J Laffin; J M Lehman
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  Simian virus 40 prevents activation of M-phase-promoting factor during lytic infection.

Authors:  F J Scarano; J A Laffin; J M Lehman; T D Friedrich
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.